Works matching AU Nojiri, Shunsuke


Results: 45
    1

    Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 4, p. 311, doi. 10.1159/000541455
    By:
    • Kato, Daisuke;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Okayama, Kohei;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Hayashi, Katsumi;
    • Kusakabe, Atsunori;
    • Hasegawa, Izumi;
    • Matoya, Sho;
    • Mizoshita, Tsutomu;
    • Kimura, Yoshihide;
    • Kondo, Hiromu;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi
    Publication type:
    Article
    2

    Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study.

    Published in:
    Oncology, 2024, v. 102, n. 8, p. 676, doi. 10.1159/000536367
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Kato, Daisuke;
    • Kusakabe, Atsunori;
    • Koguchi, Hiroki;
    • Hasegawa, Izumi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Tanaka, Yoshito;
    • Kondo, Hiromu;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke
    Publication type:
    Article
    3

    Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis.

    Published in:
    NPJ Regenerative Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41536-021-00132-4
    By:
    • Takeuchi, Suguru;
    • Tsuchiya, Atsunori;
    • Iwasawa, Takahiro;
    • Nojiri, Shunsuke;
    • Watanabe, Takayuki;
    • Ogawa, Masahiro;
    • Yoshida, Tomoaki;
    • Fujiki, Katsunori;
    • Koui, Yuta;
    • Kido, Taketomo;
    • Yoshioka, Yusuke;
    • Fujita, Mayu;
    • Kikuta, Junichi;
    • Itoh, Tohru;
    • Takamura, Masaaki;
    • Shirahige, Katsuhiko;
    • Ishii, Masaru;
    • Ochiya, Takahiro;
    • Miyajima, Atsushi;
    • Terai, Shuji
    Publication type:
    Article
    4

    A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial.

    Published in:
    Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 99, doi. 10.1159/000531377
    By:
    • Kudo, Masatoshi;
    • Ueshima, Kazuomi;
    • Saeki, Issei;
    • Ishikawa, Toru;
    • Inaba, Yoshitaka;
    • Morimoto, Naoki;
    • Aikata, Hiroshi;
    • Tanabe, Nobukazu;
    • Wada, Yoshiyuki;
    • Kondo, Yasuteru;
    • Tsuda, Masahiro;
    • Nakao, Kazuhiko;
    • Ito, Takanori;
    • Hosaka, Tetsuya;
    • Kawamura, Yusuke;
    • Kuzuya, Teiji;
    • Nojiri, Shunsuke;
    • Ogawa, Chikara;
    • Koga, Hironori;
    • Hino, Keisuke
    Publication type:
    Article
    5

    Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.

    Published in:
    Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 354, doi. 10.1159/000522547
    By:
    • Kudo, Masatoshi;
    • Ueshima, Kazuomi;
    • Ikeda, Masafumi;
    • Torimura, Takuji;
    • Tanabe, Nobukazu;
    • Aikata, Hiroshi;
    • Izumi, Namiki;
    • Yamasaki, Takahiro;
    • Nojiri, Shunsuke;
    • Hino, Keisuke;
    • Tsumura, Hidetaka;
    • Kuzuya, Teiji;
    • Isoda, Norio;
    • Moriguchi, Michihisa;
    • Aino, Hajime;
    • Ido, Akio;
    • Kawabe, Naoto;
    • Nakao, Kazuhiko;
    • Wada, Yoshiyuki;
    • Ogasawara, Sadahisa
    Publication type:
    Article
    6
    7
    8
    9

    Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.

    Published in:
    PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164418
    By:
    • Matsunami, Kayoko;
    • Nishida, Nao;
    • Kaneko, Naoko;
    • Ikeo, Kazuho;
    • Toyo-oka, Licht;
    • Takeuchi, Hiroshi;
    • Matsuura, Kentaro;
    • Tamori, Akihiro;
    • Nomura, Hideyuki;
    • Yoshiji, Hitoshi;
    • Imamura, Masatoshi;
    • Masaki, Naohiko;
    • Hayakawa, Tatsuro;
    • Ide, Tatsuya;
    • Shimada, Noritomo;
    • Ikeda, Fusao;
    • Hino, Keisuke;
    • Nishiguchi, Shuhei;
    • Okuse, Chiaki;
    • Nojiri, Shunsuke
    Publication type:
    Article
    10
    11

    Serum interleukin‐6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis.

    Published in:
    Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 10, p. 2158, doi. 10.1111/jgh.16672
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Kusakabe, Atsunori;
    • Narahara, Satoshi;
    • Tokunaga, Takayuki;
    • Nagaoka, Katsuya;
    • Murakami, Shuko;
    • Inoue, Takako;
    • Kuroyanagi, Keita;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice.

    Published in:
    Inflammation & Regeneration, 2021, v. 41, n. 1, p. 1, doi. 10.1186/s41232-021-00177-4
    By:
    • Nojiri, Shunsuke;
    • Tsuchiya, Atsunori;
    • Natsui, Kazuki;
    • Takeuchi, Suguru;
    • Watanabe, Takayuki;
    • Kojima, Yuichi;
    • Watanabe, Yusuke;
    • Kamimura, Hiroteru;
    • Ogawa, Masahiro;
    • Motegi, Satoko;
    • Iwasawa, Takahiro;
    • Sato, Takeki;
    • Kumagai, Masaru;
    • Ishii, Yui;
    • Kitayama, Tomomi;
    • Li, Yu-Tung;
    • Ouchi, Yuya;
    • Shimbo, Takashi;
    • Takamura, Masaaki;
    • Tamai, Katsuto
    Publication type:
    Article
    19
    20

    CARDIOVASCULAR TOLERANCE AND AUTONOMIC NERVOUS RESPONSES IN UNSEDATED UPPER GASTROINTESTINAL SMALL-CALIBER ENDOSCOPY: A COMPARISON BETWEEN TRANSNASAL AND PERORAL PROCEDURES WITH NEWLY DEVELOPED MOUTHPIECE.

    Published in:
    Digestive Endoscopy, 2011, v. 23, n. 1, p. 78, doi. 10.1111/j.1443-1661.2010.01064.x
    By:
    • Kataoka, Hiromi;
    • Hayano, Junichiro;
    • Mizushima, Takashi;
    • Tanaka, Mamoru;
    • Kubota, Eiji;
    • Shimura, Takaya;
    • Mizoshita, Tsutomu;
    • Tanida, Satoshi;
    • Kamiya, Takeshi;
    • Nojiri, Shunsuke;
    • Mukai, Seiji;
    • Mizuno, Kiyoshi;
    • Joh, Takashi
    Publication type:
    Article
    21

    Gut Dysbiosis Associated With Hepatitis C Virus Infection.

    Published in:
    Clinical Infectious Diseases, 2018, v. 67, n. 6, p. 869, doi. 10.1093/cid/ciy205
    By:
    • Inoue, Takako;
    • Nakayama, Jiro;
    • Moriya, Kei;
    • Kawaratani, Hideto;
    • Momoda, Rie;
    • Ito, Kiyoaki;
    • Iio, Etsuko;
    • Nojiri, Shunsuke;
    • Fujiwara, Kei;
    • Yoneda, Masashi
    Publication type:
    Article
    22

    Case–control study for the identification of virological factors associated with fulminant hepatitis B.

    Published in:
    Hepatology Research, 2009, v. 39, n. 7, p. 648, doi. 10.1111/j.1872-034X.2009.00519.x
    By:
    • Kusakabe, Atsunori;
    • Tanaka, Yasuhito;
    • Mochida, Satoshi;
    • Nakayama, Nobuaki;
    • Inoue, Kazuaki;
    • Sata, Michio;
    • Isoda, Norio;
    • Kang, Jong-Hon;
    • Sumino, Yasukiyo;
    • Yatsuhashi, Hiroshi;
    • Takikawa, Yasuhiro;
    • Kaneko, Shuichi;
    • Yamada, Gotaro;
    • Karino, Yoshiyasu;
    • Tanaka, Eiji;
    • Kato, Junji;
    • Sakaida, Isao;
    • Izumi, Namiki;
    • Sugauchi, Fuminaka;
    • Nojiri, Shunsuke
    Publication type:
    Article
    23
    24

    Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6876
    By:
    • Takanori Suzuki;
    • Kentaro Matsuura;
    • Yuta Suzuki;
    • Fumihiro Okumura;
    • Yoshihito Nagura;
    • Satoshi Sobue;
    • Sho Matoya;
    • Tomokatsu Miyaki;
    • Yoshihide Kimura;
    • Atsunori Kusakabe;
    • Satoshi Narahara;
    • Takayuki Tokunaga;
    • Katsuya Nagaoka;
    • Keita Kuroyanagi;
    • Hayato Kawamura;
    • Kayoko Kuno;
    • Kei Fujiwara;
    • Shunsuke Nojiri;
    • Hiromi Kataoka;
    • Yasuhito Tanaka
    Publication type:
    Article
    25

    Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1.

    Published in:
    2017
    By:
    • Iio, Etsuko;
    • Shimada, Noritomo;
    • Abe, Hiroshi;
    • Atsukawa, Masanori;
    • Yoshizawa, Kai;
    • Takaguchi, Koichi;
    • Eguchi, Yuichiro;
    • Nomura, Hideyuki;
    • Kuramitsu, Tomoyuki;
    • Kang, Jong-Hon;
    • Matsui, Takeshi;
    • Hirashima, Noboru;
    • Tsubota, Akihito;
    • Kusakabe, Atsunori;
    • Hasegawa, Izumi;
    • Miyaki, Tomokatsu;
    • Shinkai, Noboru;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Tanaka, Yasuhito
    Publication type:
    journal article
    26
    27
    28
    29

    Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 6, p. 883, doi. 10.1111/hepr.14189
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Sobue, Satoshi;
    • Kato, Daisuke;
    • Hayashi, Katsumi;
    • Kondo, Hiromu;
    • Anbe, Kaiki;
    • Mizoshita, Tsutomu;
    • Okayama, Kohei;
    • Okumura, Fumihiro;
    • Kimura, Yoshihide;
    • Ozasa, Atsushi;
    • Inada, Hiroki;
    • Tokunaga, Takayuki;
    • Narahara, Satoshi;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    30

    Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents.

    Published in:
    Hepatology Research, 2024, v. 54, n. 1, p. 32, doi. 10.1111/hepr.13962
    By:
    • Nagura, Yoshihito;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Ogawa, Shintaro;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Nagaoka, Katsuya;
    • Iio, Etsuko;
    • Watanabe, Takehisa;
    • Kataoka, Hiromi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    31

    The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Hepatology Research, 2023, v. 53, n. 6, p. 511, doi. 10.1111/hepr.13886
    By:
    • Matoya, Sho;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Kuroyanagi, Keita;
    • Kusakabe, Atsunori;
    • Koguchi, Hiroki;
    • Hasegawa, Izumi;
    • Miyaki, Tomokatsu;
    • Tanaka, Yoshito;
    • Kondo, Hiromu;
    • Kimura, Yoshihide;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke
    Publication type:
    Article
    32

    Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation.

    Published in:
    Hepatology Research, 2023, v. 53, n. 4, p. 289, doi. 10.1111/hepr.13864
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Urakabe, Kenji;
    • Okumura, Fumihiro;
    • Kawamura, Hayato;
    • Sobue, Satoshi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Kato, Daisuke;
    • Kusakabe, Atsunori;
    • Tanaka, Yoshito;
    • Ozasa, Atsushi;
    • Nagura, Yoshihito;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Hagiwara, Shinya;
    • Kusumoto, Shigeru;
    • Inoue, Takako;
    • Tanaka, Yasuhito
    Publication type:
    Article
    33

    Efficacy of minocycline hydrochloride aspiration sclerotherapy with additional monoethanolamine oleate aspiration sclerotherapy for symptomatic hepatic cysts.

    Published in:
    Hepatology Research, 2023, v. 53, n. 3, p. 267, doi. 10.1111/hepr.13865
    By:
    • Kimura, Yoshihide;
    • Fujiwara, Kei;
    • Matsuura, Kentaro;
    • Suzuki, Takanori;
    • Senoo, Kyouji;
    • Tsuchida, Kenji;
    • Mori, Yoshinori;
    • Hirano, Atsuyuki;
    • Nomura, Satoshi;
    • Kitagawa, Mika;
    • Tomita, Yusaku;
    • Kanaiwa, Hiroki;
    • Imazu, Mitsuki;
    • Nagura, Yoshihito;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi
    Publication type:
    Article
    34
    35
    36
    37

    Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.

    Published in:
    Hepatology Research, 2017, v. 47, n. 12, p. 1308, doi. 10.1111/hepr.12898
    By:
    • Iio, Etsuko;
    • Shimada, Noritomo;
    • Takaguchi, Koichi;
    • Senoh, Tomonori;
    • Eguchi, Yuichiro;
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Abe, Hiroshi;
    • Kato, Keizo;
    • Kusakabe, Atsunori;
    • Miyaki, Tomokatsu;
    • Matsuura, Kentaro;
    • Matsunami, Kayoko;
    • Shinkai, Noboru;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Tanaka, Yasuhito
    Publication type:
    Article
    38

    Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C.

    Published in:
    Hepatology Research, 2014, v. 44, n. 12, p. 1208, doi. 10.1111/hepr.12294
    By:
    • Matsuura, Kentaro;
    • Watanabe, Tsunamasa;
    • Iijima, Sayuki;
    • Murakami, Shuko;
    • Fujiwara, Kei;
    • Orito, Etsuro;
    • Iio, Etsuko;
    • Endo, Mio;
    • Kusakabe, Atsunori;
    • Shinkai, Noboru;
    • Miyaki, Tomokatsu;
    • Nojiri, Shunsuke;
    • Joh, Takashi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    39

    Recommendation of lamivudine-to-entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial.

    Published in:
    Hepatology Research, 2011, v. 41, n. 6, p. 505, doi. 10.1111/j.1872-034X.2011.00807.x
    By:
    • Matsuura, Kentaro;
    • Tanaka, Yasuhito;
    • Kusakabe, Atsunori;
    • Hige, Shuhei;
    • Inoue, Jun;
    • Komatsu, Masashi;
    • Kuramitsu, Tomoyuki;
    • Hirano, Katsuharu;
    • Ohno, Tomoyoshi;
    • Hasegawa, Izumi;
    • Kobashi, Haruhiko;
    • Hino, Keisuke;
    • Hiasa, Yoichi;
    • Nomura, Hideyuki;
    • Sugauchi, Fuminaka;
    • Nojiri, Shunsuke;
    • Joh, Takashi;
    • Mizokami, Masashi
    Publication type:
    Article
    40
    41
    42
    43
    44
    45